Opioid Use Persistent After Cancer Treatment

A new study found long-term opioid use common among head and neck cancer patients following radiation therapy.

Updated on Oct. 2, 2026 in Cancer

Isometric editorial illustration of a sterile medical tray holding a glass vial and a small jawbone model, representing cancer research.
A study from The Ohio State Comprehensive Cancer Center found that many head and neck cancer patients continue using prescription opioids months after radiation treatment. AI Illustration. Upload story photo >

Live Poll

Should medical providers prioritize stricter opioid tapering protocols for cancer patients to reduce dependency risks?

Researchers at The Ohio State Comprehensive Cancer Center found that a majority of head and neck cancer patients continue prescription opioid use months after completing radiation. The study highlights significant patterns of long-term dependency among individuals treated for nonmetastatic cancer.

Why it matters

The findings underscore a critical need for targeted opioid stewardship programs to effectively balance pain management with the risks of long-term dependency. Health officials are looking to identify specific risk factors that contribute to chronic usage in this patient population.

A study of 789 patients showed that 70% of those treated for head and neck cancer were still taking opioids 3 months after radiation. By 6 months post-treatment, 47.3% of the study cohort continued prescription opioid use.

The players

The Ohio State Comprehensive Cancer Center

This facility is a major research institution based in Columbus that provides advanced cancer care and clinical studies.

The details

The research tracked patients diagnosed between 2011 and 2023, noting that factors like smoking status, palliative care referrals, and prior opioid use correlate with chronic dependency. Underweight status also emerged as a significant indicator for a shorter time to the first opioid prescription.

Timeline

  1. The study analyzed patient records from October 2011 through December 2023.

  2. Researchers observed opioid use status at 3 months after radiation.

  3. Researchers observed opioid use status at 6 months after radiation.

  4. The study was published on October 1, 2026.

Health Landscape

This research provides a new evaluation of patient outcomes relative to radiation protocols established by the National Comprehensive Cancer Network guidelines. It highlights the evolution of post-treatment care by identifying specific risk factors for opioid dependency that were previously less understood.

Patients and caregivers in Columbus should discuss pain management strategies and potential dependency risks with their oncology team before starting radiation. Proactive referrals to palliative medicine may help manage long-term opioid use more safely.

The takeaway

Patients treated for head and neck cancer may face a high risk of long-term opioid use that persists well after radiation therapy ends. Discussing a structured pain management plan early in the treatment process can help reduce the reliance on prescription opioids over time.

Further reading

For more information on ongoing regional cancer research and support, visit the Cancer section.

Source note: This article includes information reported by Cancer Therapy Advisor.

Live Poll

Should medical providers prioritize stricter opioid tapering protocols for cancer patients to reduce dependency risks?